Remidio is a series b startup based in India. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Remidio develops and manufactures smartphone-based ophthalmic imaging devices to make screening for eye diseases like diabetic retinopathy and glaucoma more accessible and affordable.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky